You are here

Late-life plasma proteins associated with prevalent and incident frailty: A proteomic analysis.

TitleLate-life plasma proteins associated with prevalent and incident frailty: A proteomic analysis.
Publication TypeJournal Article
Year of Publication2023
AuthorsLiu, F, Austin, TR, Schrack, JA, Chen, J, Walston, J, Mathias, RA, Grams, M, Odden, MC, Newman, A, Psaty, BM, Ramonfaur, D, Shah, AM, B Windham, G, Coresh, J, Walker, KA
JournalAging Cell
Date Published2023 Sep 11
ISSN1474-9726
Abstract<p>Proteomic approaches have unique advantages in the identification of biological pathways that influence physical frailty, a multifactorial geriatric syndrome predictive of adverse health outcomes in older adults. To date, proteomic studies of frailty are scarce, and few evaluated prefrailty as a separate state or examined predictors of incident frailty. Using plasma proteins measured by 4955 SOMAmers in the Atherosclerosis Risk in Community study, we identified 134 and 179 proteins cross-sectionally associated with prefrailty and frailty, respectively, after Bonferroni correction (p < 1 × 10 ) among 3838 older adults aged ≥65 years, adjusting for demographic and physiologic factors and chronic diseases. Among them, 23 (17%) and 82 (46%) were replicated in the Cardiovascular Health Study using the same models (FDR p < 0.05). Notably, higher odds of prefrailty and frailty were observed with higher levels of growth differentiation factor 15 (GDF15; p  = 1 × 10 , p  = 2 × 10 ), transgelin (TAGLN; p  = 2 × 10 , p  = 6 × 10 ), and insulin-like growth factor-binding protein 2 (IGFBP2; p  = 5 × 10 , p  = 1 × 10 ) and with a lower level of growth hormone receptor (GHR, p  = 3 × 10 , p  = 2 × 10 ). Longitudinally, we identified 4 proteins associated with incident frailty (p < 1 × 10 ). Higher levels of triggering receptor expressed on myeloid cells 1 (TREM1), TAGLN, and heart and adipocyte fatty-acid binding proteins predicted incident frailty. Differentially regulated proteins were enriched in pathways and upstream regulators related to lipid metabolism, angiogenesis, inflammation, and cell senescence. Our findings provide a set of plasma proteins and biological mechanisms that were dysregulated in both the prodromal and the clinical stage of frailty, offering new insights into frailty etiology and targets for intervention.</p>
DOI10.1111/acel.13975
Alternate JournalAging Cell
PubMed ID37697678
Grant ListU01HL096812 / AG / NIA NIH HHS / United States
R01AG023629 / AG / NIA NIH HHS / United States
R01HL144483 / HL / NHLBI NIH HHS / United States
R01HL134320 / HL / NHLBI NIH HHS / United States
U01HL130114 / HL / NHLBI NIH HHS / United States
U01HL080295 / HL / NHLBI NIH HHS / United States
R01HL132320 / HL / NHLBI NIH HHS / United States
N01HC85086 / HL / NHLBI NIH HHS / United States
N01HC85083 / HL / NHLBI NIH HHS / United States
N01HC85082 / HL / NHLBI NIH HHS / United States
N01HC85081 / HL / NHLBI NIH HHS / United States
N01HC85080 / HL / NHLBI NIH HHS / United States
N01HC85079 / HL / NHLBI NIH HHS / United States
N01HC55222 / HL / NHLBI NIH HHS / United States
HHSN268201800001C / HL / NHLBI NIH HHS / United States
HHSN268200800007C / HL / NHLBI NIH HHS / United States
HHSN268201200036C / HL / NHLBI NIH HHS / United States
75N92021D00006 / HL / NHLBI NIH HHS / United States
75N92022D00005 / HL / NHLBI NIH HHS / United States
75N92022D00004 / HL / NHLBI NIH HHS / United States
75N92022D00003 / HL / NHLBI NIH HHS / United States
75N92022D00002 / HL / NHLBI NIH HHS / United States
75N92022D00001 / HL / NHLBI NIH HHS / United States
U01HL096917 / GF / NIH HHS / United States
U01HL096902 / GF / NIH HHS / United States
U01HL096899 / GF / NIH HHS / United States
U01HL096814 / GF / NIH HHS / United States
U01HL096812 / GF / NIH HHS / United States
ePub date: 
23/09